Alimera Sciences Stock (NASDAQ:ALIM)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$5.55

52W Range

$2.61 - $5.65

50D Avg

$5.56

200D Avg

$4.17

Market Cap

$301.29M

Avg Vol (3M)

$866.83K

Beta

1.25

Div Yield

-

ALIM Company Profile


Alimera Sciences, Inc., a pharmaceutical company, engages in the development and commercialization of ophthalmic pharmaceuticals in the United States and internationally. It offers ILUVIEN, an intravitreal implant for the treatment of diabetic macular edema (DME), which is a disease of the retina that affects individuals with diabetes and lead to severe vision loss and blindness; and to prevent relapse in recurrent non-infectious uveitis affecting the posterior segment of the eye. The company sells its products to physician offices, pharmacies, and hospitals through direct sales and distributors. It has a collaboration agreement with EyePoint Pharmaceuticals US, Inc. for the development and sale of insert technology to deliver other corticosteroids to the back of the eye for the treatment and prevention of eye diseases in humans or to treat diabetic macular edema. The company was incorporated in 2003 and is headquartered in Alpharetta, Georgia.

Show More

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

154

IPO Date

Nov 04, 2019

Website

ALIM Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 23Dec 22Dec 21
International Segment$24.04M$19.93M$32.29M
United States Segment$56.71M$34.20M$26.74M

Fiscal year ends in Dec 23 | Currency in USD

ALIM Financial Summary


Dec 23Dec 22Dec 21
Revenue$80.75M$54.13M$59.03M
Operating Income$-1.93M$-11.64M$-201.00K
Net Income$-20.13M$-18.11M$-4.37M
EBITDA$6.82M$-8.93M$2.38M
Basic EPS$-0.79$-2.59$-0.66
Diluted EPS$-0.79$-2.59$-0.66

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q1 24May 14, 24 | 1:40 PM
Q4 23Mar 07, 24 | 12:39 PM
Q3 23Oct 26, 23 | 7:25 PM

Peer Comparison


TickerCompany
LFCRLifecore Biomedical, Inc.
ORGOOrganogenesis Holdings Inc.
SHPHShuttle Pharmaceuticals Holdings, Inc.
DERMJourney Medical Corporation
PTPIPetros Pharmaceuticals, Inc.
ADMPAdamis Pharmaceuticals Corporation
LSDILucy Scientific Discovery Inc.
CYTHCyclo Therapeutics, Inc.
SXTCChina SXT Pharmaceuticals, Inc.